You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

docetaxel

Showing 1 - 25 of 1,239
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial (Standard ADT (androgen deprivation therapy), Standard Darolutamide,

Not yet recruiting
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Standard ADT (androgen deprivation therapy)
  • +2 more
  • (no location specified)
Jan 6, 2023

Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)

Recruiting
  • Hyperthermic Intraperitoneal Chemotherapy
  • Docetaxel
  • Guangzhou, Other (Non U.s.), China
    Sun Yat-sen Memorial Hospital
Jun 6, 2022

Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,

Recruiting
  • Hormone Sensitive Metastatic Prostate Cancer
  • +3 more
  • Docetaxel
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022

NSCLC Trial (Pembrolizumab, Docetaxel)

Active, not recruiting
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Pembrolizumab
  • Docetaxel
  • (no location specified)
Aug 18, 2022

Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)

Active, not recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022

Breast Cancer, Chemo Effect Trial (Nab paclitaxel, Docetaxel)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Nab paclitaxel
  • Docetaxel
  • (no location specified)
Feb 11, 2022

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Jun 21, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)

Not yet recruiting
  • Effect of Drug
  • Sapporo, Hokkaido, Japan
    Hokkaido University Hospital
Feb 12, 2022

Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • PROSTVAC-V
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Docetaxel
  • +6 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Docetaxel
  • +6 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
Has Results
  • Prostate Cancer
  • docetaxel
  • sorafenib tosylate
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Cincinnati, Ohio
  • +2 more
Apr 6, 2022

Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)

Recruiting
  • Head and Neck Squamous Carcinoma
  • Shanghai, China
    Shanghai East Hospital
Sep 22, 2022

Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)

Recruiting
  • Soft Tissue Sarcoma
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Mar 7, 2022

Nsclc Trial in Beijing (HL-085, Docetaxel)

Terminated
  • Nsclc
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Nov 29, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in United States (SPI-1620, Docetaxel)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • Cincinnati, Ohio
  • +4 more
Oct 8, 2021

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)

Terminated
  • Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 16, 2021

Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Davis, California
  • +2 more
Jan 5, 2023

Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasm
  • Docetaxel
  • Androgen-Deprivation Therapy (ADT)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022